Expertise in
5
conditions

Oleg B. Iaremenko

T. Shevchenko Boulevard, 13, 
Kyiv, UA 
Expertise in
5
conditions
T. Shevchenko Boulevard, 13, 
Kyiv, UA 

Overview

Oleg Iaremenko practices practicing medicine in Kyiv, Ukraine.

Mr. Iaremenko is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Necrotizing Vasculitis, Necrosis, Vasculitis, and Arthritis.

He is actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

T. Shevchenko Boulevard, 13, Kyiv, 01601, Ukraine

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 20, 2025
Intervention Type: Drug
Study Drug: LY3361237
Study Phase: Phase 2
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Biological, Drug
Study Drugs: GSK3196165, Tofacitinib, Methotrexate, Folic acid
Study Phase: Phase 3
View 1 Less Clinical Trial

13 Total Publications

Clinical-psychosocial archetypes predict short-term outcomes in inflammatory arthritis: an unsupervised segmentation study.
Clinical-psychosocial archetypes predict short-term outcomes in inflammatory arthritis: an unsupervised segmentation study.
Journal: Clinical rheumatology
Published: January 06, 2026

Frequently Asked Questions about Oleg B. Iaremenko

Is Oleg B. Iaremenko a top-rated expert for Necrotizing Vasculitis?

MediFind is an objective health platform that identifies experts based on real-world data. Oleg B. Iaremenko is classified as an Distinguished expert for Necrotizing Vasculitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Oleg B. Iaremenko participate in research or clinical trials?

Yes. Oleg B. Iaremenko has published 13 articles and abstracts on conditions like Necrotizing Vasculitis. You can view a list of Oleg B. Iaremenko's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Iaremenko's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile